Bitrobius Genetics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $949K

  • Investors
  • 8

Bitrobius Genetics General Information

Description

Developer of a synthetic gene transfer platform designed to facilitate genetic disease treatment. The company's products utilize proprietary plasmid DNA replication, intercellular movement, and DNA-secreting pores to provide mitochondrial gene delivery, therapeutic gene spreading, and polynucleotide construct design, enabling medical researchers and biotechnology companies to reach affected cells and manage gene therapy development through a unified digital environment.

Contact Information

Website
www.bitrobius.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Alderley Park, Congleton Road
  • Nether Alderley, Cheshire
  • Macclesfield SK10 4TG
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Alderley Park, Congleton Road
  • Nether Alderley, Cheshire
  • Macclesfield SK10 4TG
  • England, United Kingdom

Bitrobius Genetics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bitrobius Genetics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 14-Sep-2026 $949K Completed Generating Revenue
3. Early Stage VC 14-Sep-2023 Completed Generating Revenue
2. Grant 01-Aug-2021 $414K $420K Completed Startup
1. Early Stage VC (Series B) 01-Jul-2021 $420K $420K Completed Startup
To view Bitrobius Genetics’s complete valuation and funding history, request access »

Bitrobius Genetics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
A Ordinary
A Ordinary
To view Bitrobius Genetics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Bitrobius Genetics Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

Bitrobius Genetics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202219539-D0 Construct Inactive 22-Dec-2022
AU-2023411495-A1 Polynucleotide construct encoding a dna polymerase and a pore Pending 22-Dec-2022
EP-4638761-A1 Polynucleotide construct encoding a dna polymerase and a pore Pending 22-Dec-2022
WO-2024134216-A1 Polynucleotide construct encoding a dna polymerase and a pore Inactive 22-Dec-2022
JP-2026501319-A Polynucleotide constructs encoding dna polymerases and pores Pending 22-Dec-2022 C12N15/70
To view Bitrobius Genetics’s complete patent history, request access »

Bitrobius Genetics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bitrobius Genetics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Advanced Research + Invention Agency Government
Future Planet Capital Venture Capital Minority
KCP Nominees Corporation Minority
SCVC Venture Capital Minority
SynBioVen Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Bitrobius Genetics FAQs

  • When was Bitrobius Genetics founded?

    Bitrobius Genetics was founded in 2020.

  • Where is Bitrobius Genetics headquartered?

    Bitrobius Genetics is headquartered in Macclesfield, United Kingdom.

  • What is the size of Bitrobius Genetics?

    Bitrobius Genetics has 6 total employees.

  • What industry is Bitrobius Genetics in?

    Bitrobius Genetics’s primary industry is Drug Discovery.

  • Is Bitrobius Genetics a private or public company?

    Bitrobius Genetics is a Private company.

  • What is Bitrobius Genetics’s current revenue?

    The current revenue for Bitrobius Genetics is .

  • How much funding has Bitrobius Genetics raised over time?

    Bitrobius Genetics has raised $2.06M.

  • Who are Bitrobius Genetics’s investors?

    Advanced Research + Invention Agency, Future Planet Capital, KCP Nominees, SCVC, and SynBioVen are 5 of 8 investors who have invested in Bitrobius Genetics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process